Preliminary Programme - ICRS 2009 · Ana-Isabel Torres, Luciano De Petrocellis and Vincenzo Di...
Transcript of Preliminary Programme - ICRS 2009 · Ana-Isabel Torres, Luciano De Petrocellis and Vincenzo Di...
PHEASANT RUN S T . C H A R L E S , I L .
J U L Y 7 - 1 1 , 2 0 0 9
Buffet Breakfast (Atrium)
Didier M. Lambert,
Coco N. Kapanda,
Giulio G. Muccioli,
Geoffray Labar
and Jacques H. Poupaert
BIS[(DIALKYLTHIOCARBAMOYL)]DISULFIDE
DERIVATIVES AS POTENT AND SELECTIVE
MONOGLYCERIDE LIPASE INHIBITORS
John W. Huffman,
Valerie J. Smith,
Jianhong Chen,
Jenny L. Wiley
and Billy R. Martin
STRUCTURE-ACTIVITY RELATIONSHIPS
AT THE CB1 AND CB2 RECEPTORS FOR
1-ALKYL-3-(1-NAPHTHOYL-4
AND 8-HALOGEN SUBSTITUTED) INDOLES
Xiang-Qun (Sean) Xie,
Yuxun Zhang, Lirong
Wang, Jianzhong Chen,
Juerg Gertsch
and Dana E. Selley
DISCOVERY OF NEW CB2 LIGANDS
WITH NOVEL CHEMICAL SCAFFOLD
Michael Meyer, Betty Yao,
Anthony Daza, Yihong Fan,
Lanlan Li, Loan Miller,
Odile El Kouhen, Gin
Hsieh, Erica Wensink, Anita
Salyers, Prasant Chandran,
Michael Dart, Tongmei Li
and William Carroll
A-1036654, A NOVEL ORALLY
BIOAVAILABLE CB2-SELECTIVE AGONIST
EXHIBITING ANALGESIC ACTIVITY IN
RODENT MODELS OF OSTEOARTHRITIC
AND NEUROPATHIC PAIN
Aron H. Lichtman,
Anu Mahadevan,
Raj K. Razdan,
Sreenivasulu P. Naidu,
Steven G. Kinsey,
Bingjun Zhao, Hang Sun,
Dana E. Selley
and M. Imad Damaj
COMPARISON BETWEEN THE CB2
RECEPTOR AGONIST O-3223 AND THE
POTENT, MIXED CB1/CB2 RECEPTOR
AGONIST CP55,940 IN A BATTERY OF
NOCICEPTIVE ASSAYS
Jenny L. Wiley,
Pinglang Wang,
Anu Mahadevan,
Raj K. Razdan
and Billy R. Martin
PYRAZOLE CANNABINOIDS WITH
NON-CB1, NON-CB2 ACTIVITY
Zhuanhong Qiao,
Jian Cai,
William M. Pierce Jr.
and Zhao-Hui Song
DETERMINATION OF AN INTERNAL
DISULFIDE BOND IN THE SECOND
EXTRACELLULAR LOOP OF CANNABINOID
CB2 RECEPTOR BY MASS SPECTROMETRY
Mitzi Nagarkatti,
Rupal Pandey
and Prakash Nagarkatti
TARGETING CANNABINOID RECEPTORS
AS A NOVEL APPROACH TO PREVENT
GRAFT-VERSUS-HOST DISEASE
Orr Ofek,
Malka Attar-Namdar,
Esther Shohami,
Raphael Mechoulam
and Itai Bab
OSTEOBLASTIC CB2 CANNABINOID
RECEPTOR ACTIVATES GI PROTEIN-ERK1/2-
MAPKAPK2-CREB SIGNALING PATHWAY
Nancy E. Buckley,
Beverly McDowell,
Ehsan Taqavi
and Gideon Blumstein
DELTA-9-TETRAHYDROCANNABINOL,
CB2R AND IMMUNITY TO YEAST
INFECTION
Betty B Yao,
Odile El Kouhen,
Gin Hsieh, Yihong Fan,
Bradley A Hooker,
Loan Miller, David G
Witte, Lanlan Li,
Steve McGaraughty,
Kathleen Chu,
Madhavi Pai, Erica J
Wensink, Anita K
Salyers, Chang Z Zhu,
William A Carroll,
Michael J Dart
and Michael D Meyer
CB2 RECEPTOR-MEDIATED ANTI-
ALLODYNIC EFFECTS IN NEUROPATHIC
PAIN MODELS IS LIKELY MEDIATED
THROUGH NON-NEURONAL CELLS
Peter Nguyen, Cullen L.
Schmid, Kirsten M.
Raehal, Dana E. Selley,
Laura M. Bohn
and Laura J. Sim-Selley
BETA-ARRESTIN 2 REGULATES
CB1 RECEPTOR DESENSITIZATION
AND THC-MEDIATED
ANTINOCICEPTIVE TOLERANCE
Alex Straiker
and Ken Mackie
DIFFERENTIAL REGULATION OF DSI TIME
COURSE IN IDENTIFIED POPULATIONS OF
AUTAPTIC HIPPOCAMPAL NEURONS
Val J. Watts
and Julie A. Przybyla
EXPRESSION, LOCALIZATION, AND DRUG
MODULATION OF CANNABINOID CB1 AND
DOPAMINE D2 RECEPTOR HETERODIMERS
IN CATH.A DIFFERENTIATED
NEURONAL CELLS
Joel E. Schlosburg,
James J. Burston,
Steven G. Kinsey,
Lamont Booker,
Rehab A. Abdullah,
Jonathan Z. Long,
Dana E. Selley,
Benjamin F. Cravatt
and Aron H. Lichtman
BEHAVIORAL AND FUNCTIONAL
ADAPTATION OF THE ENDOCANNABINOID
SYSTEM FOLLOWING REPEATED
MONOACYLGLYCEROL LIPASE
(MAGL) INHIBITION
Xia Zhang
LONG-TERM DEPRESSION IN VENTRAL
TEGMENTAL DOPAMINE NEURONS
MEDIATES LEARNING TO ASSOCIATE
CANNABINOID EXPOSURE WITH
ENVIRONMENTAL CUES
Sachin Patel,
Philip J. Kingsley,
Ken Mackie,
Lawrence J. Marnett
and Danny G. Winder
REPEATED HOMOTYPIC STRESS ELEVATES
2-AG AND ENHANCES DEPOLARIZATION-
INDUCED SUPRESSION OF INHIBITION IN
BASOLATERAL AMYGDALA
Tiziana Rubino,
Natalia Realini,
Daniela Vigano’,
Guidali Cinzia
and Daniela Parolaro
URB597 RECOVERS SOME OF THE
SIGNS PRESENT IN THE DEPRESSIVE
PHENOTYPE INDUCED BY
ADOLESCENT EXPOSURE TO THC
“THE GLUTAMATE HOMEOSTASIS
HYPOTHESIS OF ADDICTION”
Medical University of South Carolina
Buffet Breakfast (Atrium)
Chris Henstridge,
Simon Arthur
and Andrew Irving
LACK OF SPECIFICITY FOR
CANNABINOID CB1 RECEPTOR
ANTAGONISTS: INTERACTIONS
WITH GPR55
Khalil Eldeeb,
Stephen Alexander,
David Pritchard
and David Kendall
LPI-EVOKED INCREASES IN
INTRACELLULAR CALCIUM
INCREASES IN MICROGLIAL
CELLS IN CULTURE
Ankur Kapur, Pingwei Zhao,
Haleli Sharir, Yushi Bai,
Marc G. Caron, Larry S. Barak
and Mary E. Abood
GPR55: TO BE OR NOT TO BE A
CANNABINOID RECEPTOR
Nariman Balenga,
Ralf Schröder,
Wolfgang Platzer, Julia Kargl,
Christopher M Henstridge,
Andrew J Irving, Evi Kostenis
and Maria Waldhoer
FUNCTIONAL SELECTIVITY OF
CANNABINOIDS ON THE NOVEL
CANNABINOID RECEPTOR GPR55
Takayuki Sugiura,
Atsushi Yamashita
and Saori Oka
LYSOPHOSPHATIDYLINOSITOL
INDUCES RAPID CYTOSKELETAL
REARRANGEMENTS AND
MORPHOLOGICAL CHANGES IN
HEK293 CELLS EXPRESSING
GPR55: FURTHER EVIDENCE
THAT LYSOPHOSPHATIDYL-
INOSITOL IS THE NATURAL
LIGAND FOR GPR55
Lisa A.Gauson,
Maria-Grazia Cascio,
Ruth A. Ross
and Roger G. Pertwee
CANNABIGEROL DISPLAYS
SIGNIFICANT POTENCY
AS A 5-HT1A RECEPTOR
ANTAGONIST
Sean D. McAllister, Darryl Lau,
Rigel T. Christian, Arash E.
Pakdel, Anne J. Zielinski,
Jasmine Lee, Dan H. Moore
and Pierre-Yves Desprez
CANNABIDIOL AS A NOVEL
INHIBITOR OF ID-1 GENE
EXPRESSION IN AGGRESSIVE
BREAST CANCER CELLS
Nicholas A. Jones,
Andrew J. Hill, Gary J. Stephens,
Claire M. Williams
and Benjamin J. Whalley
ANTICONVULSANT EFFECTS OF
CANNABIDIOL UPON
SPONTANEOUS EPILEPTIFORM
ACTIVITY IN ACUTE
HIPPOCAMPAL BRAIN SLICES
Tamás Bíró, Attila Oláh,
Balázs I. Tóth,
Gabriella Czifra,
Christos C. Zouboulis
and Ralf Paus
CANNABIDIOL AS A NOVEL
ANTI-ACNE AGENT?
CANNABIDIOL INHIBITS LIPID
SYNTHESIS AND INDUCES CELL
DEATH IN HUMAN SEBACEOUS
GLAND-DERIVED SEBOCYTES
Erin M. Rock,
Cheryl L. Limebeer,
Raphael Mechoulam
and Linda A. Parker
CANNABIDIOL (THE NON-
PSYCHOACTIVE COMPONENT OF
CANNABIS) MAY ACT AS A 5-
HT1A AUTO-RECEPTOR AGONIST
TO REDUCE TOXIN-INDUCED
NAUSEA AND VOMITING
Daniele De Filippis,
Giuseppe Esposito,
Mariateresa Ciprian,
Caterina Scuderi, Joris De Man
and Teresa Iuvone
CANNABIDIOL CONTROLS
INTESTINAL INFLAMMATION
THROUGH THE MODULATION OF
ENTERIC GLIAL CELLS
Julian Romero, Ana I Castillo,
Marta Moreno, Rosa M Tolon
and Jose Martinez-Orgado
CHARACTERIZATION OF THE
NEUROPROTECTIVE EFFECT
OF CANNABIDIOL AFTER
OXYGEN AND GLUCOSE
DEPRIVATION OF NEWBORN
MICE FOREBRAIN SLICES
INDIVIDUAL DIFFERENCES IN
RESPONSES TO DRUGS IN HUMANS
University of Chicago
Joshua A. Lile, Thomas H. Kelly
and Lon R. Hays
GABAA MODULATION OF THE
DISCRIMINATIVE STIMULUS
EFFECTS OF 9-THC IN HUMANS
Amanda Reiman CANNABIS AS A SUBSTITUTE FOR
ALCOHOL AND OTHER DRUGS
Andrea M Dlugos,
Ajna Hamidovic,
Colin A Hodgkinson,
David Goldman,
Abraham A Palmer
and Harriet de Wit
MORE AROUSED, LESS FATIGUED:
FAAH GENE POLYMORPHISMS
INFLUENCE ACUTE RESPONSE
TO AMPHETAMINE
José Alexandre S. Crippa,
Guilherme Nogueira
Derenusson, Thiago Borduqui
Ferrari, Lauro Wichert-Ana,
Fábio Duran, Rocio Martin-
Santos, Marcus Vinícius Simões,
Sagnik Bhattacharyya, Paolo
Fusar-Poli, Alaor Santos Filho,
Maria Cecília Freitas-Ferrari,
Philip K. McGuire, Antonio
Waldo Zuardi, Geraldo Busatto
Filho, Jaime Eduardo Cecílio
Hallak and Richard E. Musty
NEURAL BASIS OF ANXIOLYTIC
EFFECTS OF CANNABIDIOL (CBD)
IN GENERALIZED SOCIAL
ANXIETY DISORDER
Sara Jane Ward
and Ellen A. Walker
SEX AND CANNABINOID CB1
GENOTYPE DIFFERENTIATE
PALATABLE FOOD AND COCAINE
SELF-ADMINISTRATION
IN MICE
Daniel Thomas Malone,
Dennis Jongegan
and David Alan Taylor
THE EFFECT OF CANNABIDIOL
AND
9-TETRAHYDROCANNABINOL
ON SOCIAL INTERACTION
OF RATS
Kofi-Kermit Horton,
Sarah Bough,
Anushka Goonawardena,
John Sesay, Allyn Howlett
and Robert E. Hampson
CHRONIC RIMONABANT ALTERS
BEHAVIOR AND GENE
EXPRESSION IN HIPPOCAMPUS
DURING LEARNING
Emmanuel Shan Onaivi GENETIC BASIS OF
MARIJUANA USE
Notes:
Buffet Breakfast (Atrium)
Lourdes Ruiz-Valdepeñas,
José Antonio Martínez Orgado,
Cristina Otalora, Marta Moreno,
África Millán, Rosa María Tolón
and Julián Romero
CANNABIDIOL REDUCES
LIPOPOLYSACCHARIDE-INDUCED
VASCULAR DYSFUNCTION IN
THE MOUSE BRAIN: AN
INTRAVITAL MICROSCOPY STUDY
Stefania Petrosino,
Marcello Naccarato,
Daniela Pizzuti,
Marco Simonetto, Fabio Chiodo
Grandi, Gilberto Pizzolato
and Vincenzo Di Marzo
BLOOD ENDOCANNABINOID
AND
PALMITOYLETHANOLAMIDE
LEVELS IN HUMAN ISCHEMIC
STROKE
Ming Zhang, Martin W. Adler,
Mary Abood, Doina Ganea
and Ronald F. Tuma
THE COMBINATION TREATMENT
WITH A CB2 AGONIST AND
CB1 ANTAGONIST ATTENUATED
CEREBRAL ISCHEMIC INJURY
THROUGH DIFFERENT
MECHANISMS
Yosefa Avraham,
Nicholaos C Grigoriadis,
Iddo Magena,
Theofilos Poutahidis,
Lia Vorobiava, Yaron Ilan,
Raphael Mechoulam
and Elliot M Berry
CAPSAICIN AFFECTS BRAIN
FUNCTION IN A MODEL OF
HEPATIC ENCEPHALOPATHY
ASSOCIATED WITH FULMINANT
HEPATIC FAILURE IN MICE
Somnath Mukhopadhyay,
Ju-Ahng Lee
and Shailendra Devkota
ENDOCANNABINOID AND CB1
RECEPTOR-MEDIATED
REGULATION OF NEUROGENESIS
IN ZEBRAFISH
Geoffray Labar, Franck Borel,
Cédric Bauvois, Jean-Luc Ferrer,
Johan Wouters
and Didier M. Lambert
MOLECULAR INSIGHT INTO
MONOGLYCERIDE LIPASE, THE
ENZYME DEGRADATING
2-ARACHIDONOYLGLYCEROL
Jonathan Z. Long,
Daniel K. Nomura
and Benjamin F. Cravatt
MECHANISTIC
CHARACTERIZATION OF SELECTIVE
MONOACYLGLYCEROL LIPASE
INHIBITION REVEALS DIFFERENCES
IN CENTRAL AND PERIPHERAL
ENDOCANNABINOID METABOLISM
Martin Kaczocha,
Sherrye T. Glaser, Janiper Chae
and Dale G. Deutsch
FAAH-2 IS A LIPID DROPLET-
LOCALIZED ENZYME
THAT MEDIATES
N-ACYLETHANOLAMINE
INACTIVATION
Patricia H. Reggio,
Dow P. Hurst
and Diane L. Lynch
THE ROLE OF FATTY ACID BINDING
PROTEINS IN THE LIFE CYCLE OF
ANANDAMIDE
Lina Thors, Staffan Tavelin
and Christopher J. Fowler
TEMPERATURE-DEPENDENT
AND SATURABLE UPTAKE OF
ANANDAMIDE BY SYNTHETIC
LIPOSOMES
Alessia Ligresti, Dolores Hernan
Perez de la Ossa,
Jesús Molpeceres, Rosario
Aberturas, Mª Esther Gil,
Aniello Schiano Moriello,
Ana-Isabel Torres,
Luciano De Petrocellis
and Vincenzo Di Marzo
NANOPARTICLE-MEDIATED
CELLULAR UPTAKE-CONTROLLED
RELEASE AS A TOOL TO STUDY
ANANDAMIDE MEMBRANE
TRANSPORT
Leonie Wyffels,
Giulio G Muccioli,
Coco N Kapanda,
Sylvie De Bruyne,
Didier M Lambert
and Filip De Vosa
RADIOSYNTHESIS AND IN VIVO
EVALUATION OF [11C]- BIPHENYL-
3-YL 4-METHOXYPHENYL-
CARBAMATE AS PET TRACER FOR
IN VIVO EVALUATION OF FAAH IN
THE BRAIN
AN EVALUATION OF BRAIN ENDOCANNABINOID
SIGNALING AND ADDICTION-RELATED BEHAVIORS
Scripps Institute
Rao Rapaka, Ph.D. and Vishnudutt Purohit, D.V.M., Ph.D.
National Institute on Drug Abuse
Notes:
Buffet Breakfast (Atrium)
Cheryl L. Limebeer,
Kiran Vimuri, Holly Bedard,
Klaus-Peter Ossenkopp,
Alexandros Makriyannis
and Linda A. Parker
NAUSEATING EFFECTS OF AM-251
MAY BE PRODUCED BY THE
PERIPHERAL INVERSE-AGONIST
PROPERTIES: EVIDENCE FROM THE
CONDITIONED GAPING MODEL
IN RATS
Vincenzo Di Marzo, An
Verrijken, Antti Hakkarainen,
Stefania Petrosino, Ilse Mertens,
Nina Lundbom, Fabiana
Piscitelli, Jukka Westerbacka,
Aino Soro-Paavonen, Isabel
Matias, Luc Van Gaal
and Marja-Riitta Taskinen
INSULIN AS A NEGATIVE
REGULATOR OF
PLASMA ENDOCANNABINOID
LEVELS IN
OBESE AND NONOBESE SUBJECTS
Stefan Engeli, Anne-Christin
Lehmann, Jana Böhnke,
Verena Haas, Jürgen Janke,
Anke Strauß, Alexander Zörner,
Dimitrios Tsikas
and Jens Jordan
INFLUENCES OF DIETARY FAT ON
THE PERIPHERAL ECS IN LEAN AND
OBESE HUMAN SUBJECTS
Yossef Tam, Jie Liu,
Sándor Bátkai,
Douglas Osei-Hyiaman,
Alexandros Makriannis,
V. Kiran Vemuri, Keith Sharkey
and George Kunos
ANTI-OBESITY EFFECTS OF A NOVEL
PERIPHERALLY ACTING NEUTRAL
CANNABINOID 1 RECEPTOR
ANTAGONIST IN MICE
Nina L. Cluny,
Catherine M. Keenan,
Marnie Duncan,
Alyson Fox, Beat Lutz
and Keith A. Sharkey
THE ACTIONS OF A PERIPHERALLY
RESTRICTED CANNABINOID
CB1/CB2 RECEPTOR AGONIST
ON EXPERIMENTAL
COLITIS IN MICE
W.-S. Vanessa Ho
and Neelam Parmer
N-ARACHIDONOYL GLYCINE ACTS
AS A VASORELAXANT VIA NITRIC
OXIDE AND LARGE CONDUCTANCE
CALCIUM-ACTIVATED POTASSIUM
CHANNELS
K. Starowicz, W. Makuch,
M. Osikowicz, S. Petrosino,
F. Guadagno, V. Di Marzo
and B. Przewlocka
ANANDAMIDE INJECTED
INTRATHECALLY INDUCES
ANALGESIA MEDIATED BY A
TRPV1-DEPENDENT MECHANISM
IN NEUROPATHIC RATS
Mauro Dionisi, Leonie Norris,
David Barrett,
Stephen Alexander
and Andrew Bennett
SUSTAINED INHIBITION OF FAAH
ACTIVITY ELEVATES
ENDOCANNABINOID TONE AND
ACTIVATES PPAR NUCLEAR
RECEPTORS IN HUMAN
NEUROBLASTOMA CELLS
Steven G. Kinsey,
Jonathan Z. Long, Scott T.
O’Neal, Rehab A. Abdulla,
Justin L. Poklis, Dale L. Boger,
Benjamin F. Cravatt
and Aron H. Lichtman
FAAH AND MAGL INHIBITION
REDUCE NEUROPATHIC PAIN VIA
DISCRETE RECEPTOR-SPECIFIC
MECHANISMS OF ACTION
Kay Ahn, Douglas S. Johnson,
Mauro Mileni, David Beidler,
Jonathan Z. Long, Michele K.
McKinney, Eranthie Weerapana,
Nalini Sadagopan, Marya
Liimatta, Sarah E. Smith, Scott
Lazerwith, Cory Stiff, Satwik
Kamtekar, Keshab Bhattacharya,
Yanhua Zhang, Stephen
Swaney, Keri Van Becelaere,
Raymond C. Stevens
and Benjamin F. Cravatt
DISCOVERY AND
CHARACTERIZATION OF A HIGHLY
SELECTIVE FAAH INHIBITOR THAT
REDUCES INFLAMMATORY PAIN
Ethan Russo, Stephen Wright,
Philip Robson and Colin Stott
DOUBLE-BLIND, RANDOMIZED
WITHDRAWAL CLINICAL
TRIAL OF SATIVEX IN CENTRAL
NEUROPATHIC PAIN
IN MULTIPLE SCLEROSIS
Sabatino Maione,
Enza Palazzo, Alessia Ligresti
and Vincenzo Di Marzo
EFFECT OF PHYTOCANNABINOIDS
ON SUPRA-SPINAL
ANTINOCICEPTIVE DESCENDING
PATHWAYS IN RATS:
INVOLVEMENT OF CANNABINOID,
TRP AND ADENOSINE RECEPTORS
“CANNABINOID RECEPTORS AND
HUNTINGTON’S DISEASE”
The University of Auckland
.
Marilena Pira, Paolo Lazzari,
Stefania Ruiu, Simone Tambaro,
Christian Dessì and Luca Pani
SYNTHESIS AND BIOLOGICAL EVALUATION OF
ANALOGUES OF THE CB1 ANTAGONIST N-
PIPERIDINYL-5-(5-CHLORO-THIOPHEN-2-YL)-1-
(2’,4’-DICHLOROPHENYL)-4-METHYL-1H-
PYRAZOL-3-CARBOXAMIDE
Jianhong Chen, John W. Huffman,
Jenny L. Wiley and Billy R. Martin
SYNTHESIS OF GEMINALLY DIMETHYL
SUBSTITUTED ANALOGUES OF ∆8-THC
William Courtney LIPINS, CANNABINS AND ENCANNINS:
TOWARDS A RATIONAL NOMENCLATURE
Michael Dart, Arturo Perez-
Medrano, Tongmei Li, Sridhar
Peddi, Teo Kolasa, Meena Patel,
Xueqing Wang, Derek Nelson,
Anthony Daza, George Grayson,
Bradley Hooker, Yihong Fan,
Lanlan Li, Loan Miller, Tiffany
Garrison, Odile El-Kouhen,
Madhavi Pai, Prasant Chandran,
Anita Salyers, Gin Hsieh, Betty Yao,
Michael Meyer and William Carroll
ISOTHIAZOLYLIDENE AMIDES: A NEW SERIES OF
SELECTIVE CB2 AGONISTS FOR PAIN
MANAGEMENT
Derek Nelson, Jennifer Frost, Karin
Tietje, Steven Latshaw, Alan
Florjancic, Megan Gallagher,
William Carroll, Michael Dart,
Anthony Daza, Bradley Hooker,
George Grayson, Lanlan Li, Yihong
Fan, Loan Miller, Odile El-Kouhen,
Tiffany Garrison, Betty Yao, Prasant
Chandran, Chang Zhu, Madhavi
Pai, Gin Hsieh
and Michael Meyer
THIOPHENE BISAMIDE CB2 AGONISTS
Rangan Maitra, Yanan Zhang,
Herbert H. Seltzman, Michael
Roche, Julianne M. Tajuba, Rodney
W. Snyder, Norman Gaudette,
Timothy R. Fennell
and Brian F. Thomas
SYNTHESIS AND PHARMACOLOGICAL
CHARACTERIZATION OF QUATERNIZED
SR141716 ANALOGS THAT ANTAGONIZE
CANNABINOID RECEPTOR 1
Yanan Zhang, Ann Gilliam,
Rangan Maitra, Julianne M. Tajuba,
M. Imad Damaj,
Herbert H. Seltzman
and Brian F. Thomas
DEVELOPMENT OF BIVALENT SR141716 LIGANDS
FOR CB1 RECEPTOR DIMERS
Joong-Youn Shim LIPID MEMBRANE STRUCTURE OF THE
CANNABINOID CB1 RECEPTOR SECOND
EXTRACELLULAR LOOP
Evangelia Kotsikorou,
Diane L. Lynch,
Dow P. Hurst, Mary E. Abood
and Patricia H. Reggio
CONFORMATIONAL ANALYSIS AND
MOLECULAR DYNAMICS STUDY OF 2-
ARACHIDONOYL-SN-GLYCERO-3-
PHOSPHOINOSITOL (2-AGPI) AND 1-STEAROYL-
SN-GLYCERO-3-PHOSPHOINOSITOL (LPI)
IN A POPC BILAYER
Qing-Rong Liu, Chun-Hung Pan,
Akitoyo Hishimoto, Chuan-Yun Li,
Zheng-Xiong Xi, Alvaro Llorente-
Berzal, Maria-Paz Viveros,
Hiroki Ishiguro, Tadao Arinami,
Emmanuel Shan Onaivi
and George R. Uhl
IDENTIFICATION OF NOVEL HUMAN AND
RODENT CB2 CANNABINOID RECEPTOR
ISOFORMS AND THEIR DIFFERENTIAL
REGULATION IN BRAIN
Tricia H. Smith, Maurice R. Elphick,
Deborah L. Lewis
and Dana E. Selley
CANNABINOID RECEPTOR INTERACTING
PROTEIN (CRIP1A) ATTENUATES CONSTITUTIVE
CB1 RECEPTOR SIGNALING
AND CB1 DOWNREGULATION
Saori Oka, Shinji Kimura,
Atsushi Yamashita
and Takayuki Sugiura
LYSOPHOSPHATIDYLINOSITOL INDUCES
RAPID PHOSPHORYLATION OF P38 MITOGEN-
ACTIVATED PROTEIN KINASE IN HEK293
CELLS EXPRESSING GPR55
Chris Breivogel and Deryck Hill THE COUPLING OF CB1 RECEPTORS
WITH BETA-ARRESTIN1 AND 2
Lawrence C. Blume,
Caroline E. Bass,
George D. Dalton, Dana E. Selley
and Allyn C. Howlett
CANNABINOID RECEPTOR INTERACTING
PROTEIN (CRIP) 1A: DEVELOPMENT OF
OVEREXPRESSING NEURONAL CELLS
AND ADENO-ASSOCIATED VIRAL DELIVERY OF
CRIP1A TRANSCRIPTS IN VIVO
David F. Woodward , Neil Poloso,
Jenny W. Wang, Thierry Jolas,
David Piwnica, Robert W. Carling,
Clive L. Cornell, Hans Fliri,
Jose Martos, Simon N. Pettit
and W. Daniel Stamer
EVIDENCE FOR A BIMATOPROST-SENSITIVE
PROSTAMIDE RECEPTOR IN HUMAN OCULAR
CELLS ASSOCIATED WITH CONVENTIONAL
OUTFLOW
Brian D. Hudson
and Melanie E.M. Kelly
SIGNALLING INTERACTIONS BETWEEN CB1
RECEPTORS AND 2 ADRENERGIC RECEPTORS IN
HUMAN TRABECULAR MESHWORK CELLS
Lesley A. Ford, Anke J. Roelofs,
Luisa Mowat, Daniel Simpson
and Ruth A. Ross
EXPLORING THE ROLE OF
NOVEL CANNABINOID RECEPTORS
IN BREAST CANCER METASTASIS
Marco Koch, Susanne Kreutz,
Charlotte Böttger, Chalid Ghadban,
Horst-Werner Korf
and Faramarz Dehghani
NEUROPROTECTIVE EFFECTS OF
PALMITOYLETHANOLAMIDE (PEA)
TREATMENT ARE MEDIATED BY PEROXISOME
PROLIFERATOR-ACTIVATED
RECEPTOR (PPAR)-ALPHA
Ashley Dorning,
Tibor Harkany and Andrew Irving
ALTERATIONS IN CB1 RECEPTOR
NEURONAL POLARITY AND
AGONIST-INDUCED INTERNALIZATION
DURING MATURATION IN VITRO
Sherrica Tai, Torbjörn U.C. Järbe,
Subramanian K. Vadivel
and Alexandros Makriyannis
DISCRIMINATIVE STIMULUS FUNCTIONS OF
METHANANDAMIDE AND Δ9-THC IN RATS:
TESTS WITH AMINOALKYLINDOLES
(WIN55,212-2 AND AM678) AND ETHANOL
W.-S. Vanessa Ho
and Thomas Spelman
THE PUTATIVE ENDOTHELIAL CANNABINOID
RECEPTOR ANTAGONIST, O-1918 INHIBITS
VASCULAR LARGE CONDUCTANCE CALCIUM-
ACTIVATED POTASSIUM CHANNELS
Ryan McLaughlin, Matthew Hill,
Kara Stuhr, Cecilia Hillard
and Boris Gorzalka
FORCED SWIM EXPOSURE ELICITS RAPID
ALTERATIONS IN CORTICOLIMBIC
ENDOCANNABINOID CONTENT
Josée Guindon, Pierre Beaulieu
and Andrea Hohmann
THE ROLE OF THE ENDOGENOUS CANNABINOID
SYSTEM IN PERIPHERAL ANALGESIA
Alex X Dong, Melanie EM Kelly
and Susan E Howlett
VASOACTIVE ACTIONS OF ABNORMAL
CANNABIDIOL AND 3-(5-
DIMETHYLCARBAMOYL-PENT-1-ENYL)-N-(2-
HYDROXY-1-METHYL-ETHYL)BENZAMIDE
IN RETINAL ARTERIOLES
Qing-song Liu, Bin Pan, Wei Wang,
Jonathan Z Long, Dalong Sun,
Cecilia J Hillard
and Benjamin F Cravatt
BLOCKADE OF 2-AG HYDROLYSIS BY
SELECTIVE MONOACYLGLYCEROL LIPASE
INHIBITOR JZL184 ENHANCES RETROGRADE
ENDOCANNABINOID SIGNALING
Marcoita Gilbert
and Ken Soderstrom
MORPHOLOGICAL CHANGES IN ZEBRA
FINCH TELENCEPHALON FOLLOWING
DEVELOPMENTAL CANNABINOID EXPOSURE
Sabrina Francesca Lisboa
and Francisco Silveira Guimarães
INFLUENCE OF ENDOCANNABINOIDS ON
FLIGHT REACTION INDUCED BY A NITRIC OXIDE
DONOR (SIN-1) ADMINISTRATION INTO THE
DORSOLATERAL PERIAQUEDUCTAL GRAY
Thomas F. Gamage,
Mary M. O’Connell, Mary E. Tokarz
and Jenny L. Wiley
CHANGES IN SENSITIVITY TO THC AFTER
REPEATED ADMINISTRATION IN MALE AND
FEMALE ADOLESCENT
AND ADULT RATS
Tiffany T.-Y. Lee,
Matthew N. Hill, Caitlin J. Riebe
and Boris B. Gorzalka
EXPOSURE TO ESCALATING DOSES
OF A CANNABINOID CB1 RECEPTOR
AGONIST DURING ADOLESCENCE
SUPPRESSES ADULT NEUROGENESIS
Michal Schechter, Or Raviv,
Albert Pinhasov, Aron Weller
and Ester Fride
BLOCKADE OF THE CANNABINOID
CB1 RECEPTOR IMPAIRS MATERNAL
BEHAVIOR AND OFFSPRING DEVELOPMENT
AND PERFORMANCE AT ADULTHOOD IN MICE
Gernot Riedel,
Susan McKillop-Smith
and Lianne Robinson
ACUTE AND CHRONIC HU210
TREATMENT DIFFERENTIALLY AFFECTS
SPATIAL LEARNING AND MEMORY
Peter J. McLaughlin, V. Kiran
Vemuri, Alexandros Makriyannis,
Janel K. Hodge, Joshua P. Bow,
Rikki Miller
and Joshua Staszewski
MICROANALYSIS OF FOOD-MAINTAINED
LEVER PRESSING DISTINGUISHES EFFECTS
OF THE CB1 ANTAGONIST AM 6527
FROM THOSE OF PREFEEDING
Antonio Luchicchi, Salvatore Lecca,
Giuliano Pillolla, Stefano Carta
and Marco Pistis
INHIBITION OF FAAH ANTAGONIZES COCAINE
AND NICOTINE EFFECT ON NEURONS IN THE
NUCLEUS ACCUMBENS SHELL IN THE RAT
D. Matthew Walentiny,
Robert E. Vann, Benjamin F. Cravatt,
Aron H. Lichtman, Jonathan Z. Long,
Joel E. Schlosburg and Jenny L. Wiley
DISCRIMINATIVE STIMULUS EFFECTS OF THC
IN FAAH KNOCKOUT AND WILD-TYPE MICE
Michael E Ballard,
Gillinder Bedi, David A Gallo
and Harriet de Wit
EFFECTS OF ACUTE Δ9-THC ON PERCEPTION
AND MEMORY IN HEALTHY VOLUNTEERS –
RELATION TO VALENCE, MOOD
Divya Ramesh, Joel E. Schlosburg,
Rehab Abdulla, Jonathan Z. Long,
Benjamin F. Cravatt
and Aron H. Lichtman
INDUCTION OF PHYSICAL WITHDRAWAL
THROUGH PROLONGED ELEVATIONS OF
ENDOCANNABINOIDS
John Sesay, Anushka V.Goonawardena,
Gernot Riedel
and Robert E. Hampson
PHARMACOLOGICAL ELEVATION OF
ANANDAMIDE IMPAIRS SHORT-TERM
MEMORY BY ALTERING HIPPOCAMPAL
NEUROPHYSIOLOGY
Ludovic Brodusch, Nicolas Wagener
and David Bearman
MEDICINAL CANNABIS: HOW CANNABINOIDS
CAN HELP TREATING ATTENTION DEFICIT /
HYPERACTIVITY DISORDER (ADHD)?
Philippe Lucas A PATIENT SURVEY OF CANADA’S
MEDICAL CANNABIS PROGRAM AND PRODUCT
Shimon Rabichev, Yael Winter
and Ester Fride
CANNABINOID CB1 RECEPTOR ANTAGONIST
BLOCKADE AT BIRTH MAY BE ASSOCIATED
WITH ADHD
Jeffrey Hergenrather
and David Bearman
THE AMERICAN ACADEMY
OF CANNABINOID MEDICINE
Shelley L. Amen
and Cecilia J. Hillard
CHRONIC COCAINE TREATMENT,
WITHDRAWAL AND CHALLENGE ELICIT BRAIN
REGIONAL ALTERATIONS IN ANANDAMIDE
(AEA) CONCENTRATION AND FATTY ACID
AMIDE HYDROLASE (FAAH) ACTIVITY
Vinod K. Yaragudri, Suham A. Kassir,
Basalingappa L. Hungund,
Thomas B. Cooper, John Mann
and Victoria Arango
SELECTIVE ALTERATIONS IN THE CB1 RECEPTOR
AND THE FATTY ACID AMIDE HYDROLASE
IN THE VENTRAL STRIATUM OF
ALCOHOLIC AND SUICIDE VICTIMS
Hiroki Ishiguro, Yasue Horiuchi,
Maya Ishikawa, Aoi Syu,
Minori Koga, Emmanuel Onaivi,
Makoto Takahashi, Akiyoshi Kakita,
Hitoshi Takahashi, Hiroyuki Nawa
and Tadao Arinami
BRAIN CANNABINOID CB2
RECEPTOR AND SCHIZOPHRENIA
Krishna Kaphle
and S. Gautam
CANNABIS SATIVA USE IN
FOOD CULTURE OF NEPAL
Linda Klumpers, Christine Roy,
Franck Poitiers, Sandrine Turpault
and Joop van Gerven
CB1-ANTAGONIST SURINABANT INHIBITS THC-
EFFECTS IN HUMAN THC-CHALLENGE TEST
Jennifer M. Vollmer, Daniel J. Fridberg,
Patrick D. Skosnik
and Brian F. O’Donnell
THE RELATIONSHIP BETWEEN
SCHIZOTYPAL PERSONALITY TRAITS
AND CHRONIC CANNABIS USE
Patrick D. Skosnik, Giri P. Krishnan,
Adam B. Steinmetz, Chad R. Edwards,
Jennifer M. Vollmer, William P. Hetrick,
and Brian F. O’Donnell
DISRUPTION OF THE GAMMA-BAND AUDITORY
STEADY-STATE EEG RESPONSE BY
CANNABINOIDS IN HUMANS
Yuki Yamasaki, Naoki Amada,
Akihito Watanabe,
Serena Deiana, Tetsuro Kikuchi
and Gernot Riedel
EFFECTS OF CANNABIGEROL (CBG)
ON CONDITIONED AVOIDANCE
RESPONDING IN RATS
Sharon Anavi-Goffer, Shimon Rabichev,
Hodaia Matan, Ken Mackie,
Ruth A. Ross and Ester Fride
POSTNATAL NMDA-INHIBITION
INDUCES ALTERATIONS IN CB1 RECEPTOR
EXPRESSION LEADING TO SCHIZOPHRENIC-LIKE
BEHAVIOUR IN ADULTHOOD
Christopher J. Roberts
and Cecilia J. Hillard
SEXUAL DIMORPHISM IN CB1R-MEDIATED
RECOVERY FROM STRESS-INDUCED
HPA AXIS ACTIVATION
David Bearman
CLINICAL APPLICATION OF BASIC
RESEARCH:CANNABIS AND CANNABINOIDS IN
THE TREATMENT OF ADD/ADHD
David Alan Taylor,
Elaine Hoi Ling Wong,
Theo Mantamadiotis
and Daniel Thomas Malone
LACK OF BEHAVIOURAL
AND NEUROMOLECULAR EFFECTS OF
CHRONIC PUBERTAL WIN 55,512-2
TREATMENT IN ADULT RATS
Naoki Amada, Akihito Watanabe,
Yuki Yamasaki,
Serena Deiana, Tetsuro Kikuchi
and Gernot Riedel
EFFECTS OF AM281 AND CANNABIGEROL
PURIFIED FROM CANNABIS EXTRACTS
ON STEREOTYPED BEHAVIOUR
INDUCED BY APOMORPHINE
Tara Halpern, Mersiha Mehanovic,
Norman Schanz, Robert Benno
and Emmanuel Onaivi
CANNABINOID-INDUCED BEHAVIORAL
EFFECTS IN A MOUSE MODEL OF
AUTISM SPECTRUM DISORDERS
Bradley E. Alger
and Meina Wang
ACUTE RESTRAINT STRESS ENHANCES
HIPPOCAMPAL ENDOCANNABINOID FUNCTION
VIA GLUCOCORTICOID RECEPTOR ACTIVATION
Matthew N. Hill,
Cecilia J. Hillard
and Bruce S. McEwen
REMOVAL OF ADRENAL STEROIDS
MODULATES CORTICOLIMBIC
ENDOCANNABINOID SIGNALING
Notes:
Lalita D. Shrestha
and Cecilia J. Hillard
STUDIES OF POST-TRANSLATIONAL
MODIFICATIONS OF NEURONAL
MONOACYLGLYCEROL LIPASE
Eric L. Barker, Ekaterina A. Placzek,
Bruce R. Cooper, Andrew T. Placzek,
Julia A. Chester and V. Jo Davisson
LIPIDOMIC ANALYSIS OF ANANDAMIDE
METABOLITES REVEALS NOVEL
BIOTRANSFORMATION PATHWAYS
Seon A. Hepburn, John W. Huffman,
Dow Hurst, Patricia H. Reggio,
Jenny L. Wiley and Billy R. Martin
1-METHOXY ANALOGS OF CP-47,497
Bright Okine, Leonie Norris,
Annie Patel, Peter Christensen,
Steve Alexander,David Kendall,
David Barrett, Andrew Bennett
and Victoria Chapman
EFFECTS OF ACUTE VERSUS
REPEATED INHIBITION OF FAAH
ON ENDOCANNABINOID SYNTHESIS
AND CATABOLISM IN THE
MIDBRAIN AND LIVER
Natsuo Ueda, Jun Wang, Li-Ying Zhao,
Toru Uyama, Kazuhito Tsuboi
and Takeharu Tonai
AMINO ACID RESIDUES IMPORTANT FOR PH
DEPENDENCY AND PROTEOLYTIC MATURATION
OF N-ACYLETHANOLAMINE- HYDROLYZING
ACID AMIDASE (NAAA)
Michele K. McKinney
and Benjamin F. Cravatt
NEXT GENERATION MOUSE MODELS FOR
FATTY ACID AMIDE HYDROLASE
Jacqueline L. Blankman,
Gabriel M. Simon,
Michele K. McKinney
and Benjamin F. Cravatt
CHARACTERIZATION OF NOVEL MOUSE
BRAIN 2-AG HYDROLASES
Amy Sasman and Cecilia Hillard
CIRCADIAN PATTERNS IN MRNA
EXPRESSION AND ACTIVITY OF FATTY
ACID AMIDE HYDROLASE
Toru Uyama, Jun Morishita,
Xing-Hua Jin, Yasuo Okamoto,
Kazuhito Tsuboi and Natsuo Ueda
THE TUMOR SUPPRESSOR H-REV107 FUNCTIONS
AS PHOSPHOLIPASE A1/2 WITH A LOW
N-ACYLTRANSFERASE ACTIVITY
Nadine M. Ulloa and Dale G. Deutsch NAM INHIBITION OF MAGL: COMPARISON OF
A COLORIMETRIC AND RADIOMETRIC ASSAY
Stephen PH Alexander and Annie Patel
4-NITROPHENYLACETATE AS A POTENTIAL
SUBSTRATE FOR MAG LIPASE: INVESTIGATION OF
AN ASSAY SUITABLE FOR HIGH-THROUGHPUT
SCREENING USING RAT TISSUES
Alexander A. Zoerner, Frank M. Gutzki,
Maria T. Suchy, Bibiana Beckmann,
Stefan Engeli, Jens Jordan
and Dimitrios Tsikas
TARGETED STABLE-ISOTOPE DILUTION GC-MS/MS
DETERMINATION OF THE ENDOCANNABINOID
ANANDAMIDE AND OTHER FATTY ACID
ETHANOL AMIDES IN HUMAN PLASMA
Sherry Shu-Jung Hu,
Jonathan Long, Andy Arnold,
Jim Wager-Miller, Ben Cravatt,
Ken Mackie and Alex Straiker
MONOACYL GLYCEROL LIPASE (MGL) LIMITS THE
DURATION OF ENDOCANNABINOID-MEDIATED
DEPOLARIZATION-INDUCED SUPPRESSION OF
EXCITATION (DSE) IN AUTAPTIC HIPPOCAMPAL
NEURONS
Emmelie Björklund, Erika Norén,
Johanna Nilsson, Yanlin Hu,
and Christopher J. Fowler
THE PEROXISOME PROLIFERATOR-ACTIVATED
RECEPTOR LIGAND TROGLITAZONE IS A
POTENT INHIBITOR OF MONOACYLGLYCEROL
LIPASE
Philip J. Kingsley, Sachin Patel
and Lawrence J. Marnett
SIMULTANEOUS ANALYSIS OF 2-
ARACHIDONOYLGLYCEROL, ARACHIDONIC
ACID AND SELECTED DIACYLGLYCEROLS
BY LC-ESI-MS/MS
Maria Grazia Cascio, Lisa A. Gauson,
Lesley A. Stevenson, Ruth A. Ross
and Roger G. Pertwee
CANNABIGEROL BEHAVES AS A POTENT
ALPHA-2-ADRENOCEPTOR PARTIAL AGONIST
Samir A. Ross, Mohamed M. Radwan,
Safwat A. Ahmed, Desmond Slade,
Anwen Eslinger, Olivia Dale,
Susan Manly, Stephen Cutler
and Mahmoud A. ElSohly
BINDING AFFINITIES OF MINOR CANNABIS
CONSTITUENTS TO CB1 AND CB2 RECEPTORS
Dolores Hernán, Guillermo Velasco,
Mar Lorente, Sofía Torres,
Mª Esther Gil
and Ana-Isabel Torres
CHARACTERIZATION AND
IN VIVO EVALUATION OF A
CONTROLLED RELEASE DELIVERY SYSTEM
FOR Δ9-TETRAHYDROCANNABINOL
ADMINISTRATION
Serena Deiana , Akihito Watanabe,
Yuki Yamasaki, Naoki Amada,
Tetsuro Kikuchi and Gernot Riedel
EFFECTS OF TETRAHYDROCANNABIVARIN
(THCV) AND RISPERIDONE ON MK-801-INDUCED
SOCIAL RECOGNITION DEFICITS IN RATS
Colin Stott, Leo Ayerakwa,
Stephen Wright,
Tetsuro Kikuchi
and Geoffrey Guy
THE GENOTOXICOLOGY OF
PHYTOCANNABINOIDS
Alistair VW Nunn, Jimmy D Bell
and Geoffrey W Guy
FROM PLANT POLYPHENOL STRESS PATHWAYS
TO THE ENDOCANNABINOID SYSTEM:
CO-EVOLVED MODULATION OF BEHAVIOUR
AND BIOENERGETICS
Akihito Watanabe , Yuki Yamasaki,
Naoki Amada, Serena Deiana ,
Tetsuro Kikuchi and Gernot Riedela
EVALUATION OF THE PURIFIED THCV AND
PLANT EXTRACTS RICH IN THCV
IN THE MOUSE IRWIN TEST
Andrew J. Hill, Samantha E. Weston,
Nicholas A. Jones,
Elizabeth M. Williamson,
Gary J. Stephens, Benjamin J. Whalley
and Claire M. Williams
ANTI-CONVULSANT PROPERTIES OF
9-THCV IN ADULT RATS IN CHEMICALLY-
INDUCED SEIZURES
Imogen Smith, Sarah Bevan,
Ben Whalley and Gary Stephens
PHYTOCANNABINOID AFFINITIES AT CB1
RECEPTORS IN THE MOUSE CEREBELLUM
Jahan P. Marcu, Rigel T. Christian,
Anne Zielinski, Maxx P. Horowitz,
Darryl Lau, Dan H. Moore,
Pierre-Yves Desprez, Garret L. Yount
and Sean D. McAllister
PLANT WISDOM: CANNABIDIOL SYNERGIZES
WITH Δ9-TETRAHYDROCANNABINOL TO INHBIT
HUMAN GLIOBLASTOMA PROLIFERATION AND
SURIVAL
Somnath Mukhopadhyay,
Inneke Johnson, Susana C. Hilderbrand,
Tonya Gerald and David Tulis
CB2 CANNABINOID RECEPTOR-MEDIATED
S-NITROSYLATION OF MATRIX
METALLOPROTEINASE IN ENDOTHELIAL
CELLS: A NOVEL MECHANISM FOR THE
REGULATION OF ANGIOGENESIS
Filomena Fezza, Monica Bari,
Paolo Maturo, Valeria Gasperi,
Raffaella Docimo
and Mauro Maccarrone
ANANDAMIDE METABOLISM IN GINGIVAL
CREVICULAR FLUID AND PERIODONTAL TISSUE
Nissar A. Darmani,
Seetha Chebolu, Andrew P. Ray
and Yaozhi Wang
WIN55, 212-2 PREVENTS LEUKOTRIENE-INDUCED
VOMITING IN THE LEAST SHREW (Cryptotis parva)
Hodaya Dahan, Aron Weller
and Ester Fride
CANNABINOID CB1 RECEPTOR BLOCKADE AT
BIRTH CAUSES GROWTH FAILURE DUE TO ORAL
MOTOR WEAKNESS AND IS MEDIATED BY
PERIPHERAL MECHANISMS
Stefan Engeli, Matthias Blüher,
Andrea Bosse-Henck,
Sandor Batkai, Pal Pacher,
Judy Harvey-White,
George Kunos
and Jens Jordan
CIRCULATING ENDOCANNABINOIDS ARE
RELATED TO BLOOD PRESSURE IN PATIENTS
WITH OBSTRUCTIVE SLEEP APNEA
Fabiana Piscitelli, Angelo A. Izzo,
Raffaele Capasso, Stefania Petrosino
and Vincenzo Di Marzo
ALTERATIONS OF BASAL AND
FASTING/REFEEDING-REGULATED TISSUE
LEVELS OF ENDOGENOUS N-ACYL-
ETHANOLAMINE LIGANDS OF PPAR-
IN OBESE ZUCKER RATS
Amanda R. Jones, M. Jerry Wright Jr.
and Jenny L. Wiley
EFFECT OF HIGH-FAT DIET ON THE SENSITIVITY
TO DELTA-9-TETRAHYDROCANNABINOL IN
FEMALE LONG-EVANS RATS
Natalia Battista, Felice Francavilla,
Arcangelo Barbonetti,
Vassallo Maria Rosaria, Cinzia Rapino,
Carla Antonangelo,
Nicoletta Pasquariello,
Barbara Barboni
and Mauro Maccarrone
FERTILIZING ABILITY OF HUMAN
SPERM IS CONTROLLED
BY TRPV1 VANILLOID RECEPTOR
Luciano De Petrocellis,
Paola Grimaldi, Pierangelo Orlando,
Sara Di Siena, Francesca Lolicato,
Stefania Petrosino, Tiziana Bisogno,
Raffaele Geremia
and Vincenzo Di Marzo
CB2 RECEPTORS IN MOUSE MALE GERM CELL
DIFFERENTIATION
Caitlin J. Riebe, Tiffany T. Lee,
Matthew N. Hill
and Boris B. Gorzalka
ESCALATING ADMINISTRATION
OF CANNABINOIDS DURING ADOLESCENCE
AUGMENTS MALE COPULATORY
BEHAVIOR IN ADULTHOOD
Xiaofei Sun and Sudhansu K. Dey ABERRANT ENDOCANNABINOID SIGNALING
COMPROMISES EPIDIDYMAL FUNCTION
Mariateresa Cipriano, Caterina Scuderi,
Daniele De Filippis, Giuseppe Esposito,
Antonio Steardo, Vincenzo Di Marzo
and Teresa Iuvone
PALMITOYLTHENOLAMIDE CONTROLS BETA
AMYLOID-INDUCED GLIAL HYPERACTIVATION
Julie M. Ziobro, Robert E. Blair,
Laxmikant S. Deshpande
and Robert J. DeLorenzo
WIN 55,212-2 MEDIATED NEUROPROTECTION
AND PREVENTION OF EPILEPTOGENESIS
FOLLOWING GLUTAMATE-INJURY
IN AN ORGANOTYPIC HIPPOCAMPAL
SLICE CULTURE MODEL
Cristina Benito, Ana Isabel Castillo,
Lourdes Ruiz-Valdepeñas,
Alicia López, Cristina Otalora,
Rosa M. Tolón, José Martínez-Orgado,
Benjamin F Cravatt and Julián Romero
THE GENETIC ABLATION OF FAAH MODIFIES
THE ASTROCYTIC RESPONSE AGAINST BETA
AMYLOID PEPTIDE
Lourdes Ruiz-Valdepeñas,
Cristina Benito, Alicia López,
Cristina Otalora, Rosa M. Tolón,
Benjamin F. Cravatt and Julián Romero
THE SELECTIVE DELETION OF FAAH ALTERS THE
APPEARANCE OF BETA AMYLOID PLAQUES IN
AN ANIMAL MODEL OF ALZHEIMER’S DISEASE
Megan Dowie, Douglas McHugh,
Heather Bradshaw, Monique Howard,
Louise Nicholson, Richard Faull,
Anthony Hannan and Michelle Glass
MOLECULAR IMPACTS OF CHRONIC
CANNABINOID TREATMENT IN HUNTINGTON’S
DISEASE TRANSGENIC MICE
Carla Pisu, Stefania Marcello,
Paolo Lazzari, Giovanni Loriga,
Stefania Ruiu, Christian Dessì,
Matteo Falzoi, Luigi Pira
and Luca Pani
RECEPTORIAL AND PHARMACOLOGICAL
CHARACTERIZATION OF THE NEW
CANNABINOID AGONIST NESS040C5
Xueqing Wang, Teodozyj Kolasa,
Jennifer M. Frost, Meena V. Patel,
Steven P. Latshaw, Arturo Perez-
Medrano, Sridhar Peddi, William A.
Carroll, Michael J. Dart, Anthony Daza,
George Grayson, Yihong Fan, Loan
Miller, Lanlan Li, Bradley A. Hooker,
Tiffany Garrison, Odile F. El-Kouhen,
Prasant Chandran, Anita Salyers,
Madhavi Pai, Gin Hsieh, Betty Yao
and Michael Meyer
CYANOAMIDINE ANALOGS OF N-
THIAZOLYLIDENE CARBOXIMIDE: POTENT,
SELECTIVE CANNABINOID CB2 AGONIST AS
NOVEL PAIN THERAPEUTICS
Bo Liu, Keith Ryther, Xueqing Wang,
Anthony Daza, Lanlan Li,
George Grayson, Yihong Fan,
Loan Miller, Bradley Hooker,
Tiffany Garrison, Odile El-Kouhen,
Chang Zhu, Gin Hsieh, Betty Yao,
Michael Dart and Michael Meyer
STRUCTURE-ACTIVITY RELATIONSHIP STUDIES
ON A NOVEL SERIES OF IMIDAZOPYRIDINE
DERIVATIVES AS CANNABINOID RECEPTOR 2
(CB2) AGONISTS
Elizabeth J. Rahn, Ganesh A. Thakur,
Alexander M. Zvonok,
V. Kiran Vemuri,
Alexandros Makriyannis
and Andrea G. Hohmann
PHARMACOLOGICAL CHARACTERIZATION OF
PUTATIVE CANNABINOID CB2 AGONISTS FROM
THE CANNABILACTONE CLASS:
ANTINOCICEPTION WITHOUT CENTRAL
NERVOUS SYSTEM SIDE-EFFECTS
Lamont Booker, Steven G. Kinsey,
Kay Ahn, Benjamin F. Cravatt
and Aron H. Lichtman
FAAH INHIBITION REVERSES
LIPOPOLYSACCHARIDE-INDUCED
MECHANICAL ALLODYNIA
Christopher J. Fowler, Lina Thors,
James J Burston, Benedict J. Alter,
Michele K. McKinney,
Benjamin F. Cravatt, Ruth A. Ross,
Roger G. Pertwee, Robert W. Gereau
and Jenny L. Wiley
BIOCHANIN A: A NATURALLY OCCURRING,
PERIPHERALLY ACTING INHIBITOR OF FATTY
ACID AMIDE HYDROLASE
Joel Musee and Lawrence J. Marnett SUBSTRATE SPECIFICITY IN THE
ACTIVATION OF COX-2
Mark Ware, Tongtong Wang,
Stan Shapiro and Jean-Paul Collet
CANNABIS FOR THE MANAGEMENT OF PAIN:
ASSESSMENT OF SAFETY STUDY (COMPASS)
Mauro Maccarrone, Nicoletta
Pasquariello, Giuseppina Catanzaro,
Valeria Marzano, Daniele Amadio,
Daniela Barcaroli, Sergio Oddi,
Giorgio Federici, Andrea Urbani
and Alessandro Finazzi-Agrò
PROTEOMIC ANALYSIS OF
ANANDAMIDE-INDUCED APOPTOSIS
IN HUMAN NEURONAL CELLS
Luciano De Petrocellis,
Alessia Ligresti,
Aniello Schiano Moriello,
Marco Allarà, Pierangelo Orlando
and Vincenzo Di Marzo
EFFECT OF PHYTOCANNABINOIDS ON HUMAN
PROSTATE CARCINOMA CELLS
D. Petit, C. Kramer
and P. Bagavandoss
DIFFERENTIAL EFFECTS OF THE ANTIOXIDANTS
ALPHA TOCOPHEROL AND BUTYLATED
HYDROXYANISOLE (BHA) ON AM251-INDUCED
ENDOTHELIAL CELL GROWTH INHIBITION
Natsuo Ueda, Jun Wang,
Li-Ying Zhao, Toru Uyama
and Kazuhito Tsuboi
EXPRESSION OF ANANDAMIDE-RELATED
ENZYMES IN HUMAN PROSTATE CANCER CELLS
Laurie Hamtiaux, Laurie Hansoulle,
Giulio Muccioli and Didier M Lambert
DECREASE OF TUMOR CELL VIABILITY VIA
INHIBITION OF ENDOCANNABINOID
DEGRADATION BY URB597
R. Bryan Rock,
Shuxian Hu, Wen S. Sheng
and Phillip K. Peterson
WIN55,212-2 PROTECTS HUMAN DOPAMINERGIC
NEURONS AGAINST GP120-INDUCED DAMAGE
Thitirat Ngaotepprutaram,
Barbara L.F. Kaplan,
Robert B. Crawford,
and Norbert E. Kaminski
DELTA9-TETRAHYDROCANNABINOL (∆9-THC)
SUPPRESSES CD40 LIGAND (CD40L)
UPREGULATION IN ACTIVATED CD4+ T CELLS
Ehsan Taqavi, Gideon Blumstein
and Nancy E. Buckley
EFFECTS OF CHRONIC THC TREATMENTS ON
ADAPTIVE IMMUNE RESPONSES TO CANDIDA
ALBICANS INFECTED C57BL/6 MICE
Beverly McDowell
and Nancy E. Buckley
THE EFFECTS OF THC ON THE INNATE IMMUNE
RESPONSE TO SYSTEMIC CANDIDA ALBICANS
INFECTION IN MICE
Kristen Peskuski
PUTATIVE ABBERATION OF THE
ENDOGENOUS CANNABINOID SYSTEM:
A CASE STUDY
Weimin Chen, Peer W. F. Karmaus,
Barbara L.F. Kaplan
and Norbert E. Kaminski
REDUCED CYTOTOXIC T LYMPHOCYTE (CTL)
EFFECTOR RESPONSES IN CANNABINOID
RECEPTORS 1 AND 2 DEFICIENT MICE IN VITRO
Peer Karmaus, Weimin Chen,
Barbara Kaplan and Norbert Kaminski
Δ9-TETRAHYDROCANNABINOL DIRECTLY
IMPAIRS CYTOTOXIC T LYMPHOCYTE EFFECTOR
FUNCTION DURING DIFFERENTIATION
Michiel GJ Balvers,
Kitty CM Verhoeckx, Jocelijn Meijerink,
Pierluigi Plastina
and Renger F Witkamp
FORMATION AND IMMUNE MODULATING
ACTIVITIES OF THE ETHANOLAMIDE FROM
DOCOSAHEXAENOIC ACID IN 3T3L1
ADIPOCYTES AND RAW 264.7 MACROPHAGES
Priyadarshini Raman, Barbara L.F.
Kaplan, Jerry T. Thompson,
John P. Vanden Heuvel
and Norbert E. Kaminski
PEROXISOME PROLIFERATOR ACTIVATED
RECEPTOR IS ACTIVATED BY 15D-PGJ2-G,
A PUTATIVE METABOLITE OF
2-ARACHIDONYL GLYCEROL
2009 © International Cannabinoid Research Society, Inc.